AU2003204221A1 - Dipyridoimidazolderivatives useful in treating central nervous system disorders - Google Patents
Dipyridoimidazolderivatives useful in treating central nervous system disordersInfo
- Publication number
- AU2003204221A1 AU2003204221A1 AU2003204221A AU2003204221A AU2003204221A1 AU 2003204221 A1 AU2003204221 A1 AU 2003204221A1 AU 2003204221 A AU2003204221 A AU 2003204221A AU 2003204221 A AU2003204221 A AU 2003204221A AU 2003204221 A1 AU2003204221 A1 AU 2003204221A1
- Authority
- AU
- Australia
- Prior art keywords
- dipyridoimidazolderivatives
- useful
- nervous system
- central nervous
- system disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000008779 central nervous system disease Diseases 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003204221A AU2003204221B2 (en) | 1997-10-07 | 2003-05-15 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60061248 | 1997-10-07 | ||
PCT/US1998/020802 WO1999018105A1 (en) | 1997-10-07 | 1998-10-05 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
AU10664/99A AU1066499A (en) | 1997-10-07 | 1998-10-05 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
AU2003204221A AU2003204221B2 (en) | 1997-10-07 | 2003-05-15 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10664/99A Division AU1066499A (en) | 1997-10-07 | 1998-10-05 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003204221A1 true AU2003204221A1 (en) | 2003-06-19 |
AU2003204221B2 AU2003204221B2 (en) | 2006-07-27 |
Family
ID=39339719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003204221A Ceased AU2003204221B2 (en) | 1997-10-07 | 2003-05-15 | Dipyridoimidazolderivatives useful in treating central nervous system disorders |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2003204221B2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69329654T2 (en) * | 1992-08-19 | 2001-03-15 | Mcneilab Inc | 3-OXO-PYRIDO [1,2-A] BENZIMIDAZOLE-4-CARBOXYL AND 4-OXO-AZEPINO [1,2-A] BENZIMIDAZOLE-5-CARBOXYL DERIVATIVES SUITABLE FOR THE TREATMENT OF CENTRAL SYSTEM DISEASES |
-
2003
- 2003-05-15 AU AU2003204221A patent/AU2003204221B2/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL324313A1 (en) | 10-axcyloxy 10,11-dihydrobenz/b,f/azepin-5-carboxyamides useful in treating nervous system disorders | |
PL337888A1 (en) | Imidazoprimidines and imidazopyridines for use in treating neurological disorders | |
PL336290A1 (en) | Sulphonamides for treating endothelin-involving disorders | |
AU3153295A (en) | Methods for treating addictive disorders | |
AU9262598A (en) | Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders | |
AU8769098A (en) | System for treating patients with anxiety disorders | |
AU7383398A (en) | Therapeutic glasses and method for using the same | |
ZA977945B (en) | Hydrogenation process | |
HUP0003964A2 (en) | Methods for treating thrombotic disorders | |
AU1620699A (en) | Middle distillate selective hydrocracking process | |
GB2319796B (en) | Formation treatment method using deformable particles | |
AU7600198A (en) | Formation treatment method using deformable particles | |
HK1018272A1 (en) | Substituted pyridylmethylpiperazine and piperidinederivatives, their preparation and their use for treating central nervous system (cns) disorders | |
AU6859096A (en) | Substituted cyclohexylamines as central nervous system agents | |
EP1011330A4 (en) | Central nervous system axon regeneration | |
AU1184399A (en) | Therapeutic molecules | |
AU5298699A (en) | Dnazymes and methods for treating hpv-related disorders | |
AU6242498A (en) | Methods for treating central and peripheral nerve pain | |
PL332313A1 (en) | Application of benzopyranoles in treatment of neurological disorders | |
PL332821A1 (en) | Pyrazolydinones for treating potency disorders | |
AU2892995A (en) | Authentication technique | |
GB2359316B (en) | Formation treatment method using deformable particles | |
AU4239597A (en) | Novel pharmacotherapeutic process and composition for central nervous system disorders | |
AU6300898A (en) | Well treatment with particles | |
HUP9902802A3 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |